No Data
No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Guizhou Chitianhua Co., Ltd. 2024 Annual Results Pre-loss Announcement
Guizhou Chitianhua (600227.SH): Expected net loss of 69 million yuan to 0.104 billion yuan in 2024.
On January 17, Gelonghui reported that Guizhou Chitianhua (600227.SH) announced that, according to preliminary calculations by the finance department, it is expected that the net income attributable to the parent company's owners for the year 2024 will be between -69 million yuan and -103.5 million yuan, indicating a loss compared to the same period last year (statutory disclosure data). It is expected that the net income attributable to the parent company's owners, after excluding non-recurring gains and losses, will be between -90 million yuan and -124.5 million yuan for the year 2024. 1. Medical Services Sector: 2024 will be the first accounting year of complete Operation for the company's hospitals, which are still in the initial stage.
Benign Growth For Guizhou Chitianhua Co.,Ltd. (SHSE:600227) Underpins Stock's 29% Plummet
Individual Investors Among Guizhou Chitianhua Co.,Ltd.'s (SHSE:600227) Largest Stockholders and Were Hit After Last Week's 10% Price Drop
The management team of Guizhou Chitianhua (600227.SH) completed a Shareholding of 666,900 shares.
Guizhou Chitianhua (600227.SH) announced that, as of December 31, 2024, the implementation period for this shareholding plan...
Some Guizhou Chitianhua Co.,Ltd. (SHSE:600227) Shareholders Look For Exit As Shares Take 27% Pounding
